M. O. Karlsson
- Oncology top 10%
- Pharmacology top 5%
- Molecular Biology
- Statistics and Probability top 5%
- Pediatrics, Perinatology and Child Health
- Co-authors
- E. Niclas JonssonJanet R. WadeCurtis G. WiltseMarie SandströmAgneta FreijsAlex SparreboomLena E. FribergArne Melander
- Topics
- Cancer Treatment and Pharmacology (7 papers)Pharmacogenetics and Drug Metabolism (6 papers)Statistical Methods in Clinical Trials (4 papers)
- Journals
- Journal of Clinical OncologyJournal of Pharmacology and Experimental TherapeuticsEuropean Journal of Cancer
- Partner nations
- SwedenNetherlandsUnited States
In The Last Decade
M. O. Karlsson
17 papers receiving 602 citations
Peers
Comparison fields: 5 of 103
- Oncology 272
- Pharmacology 119
- Molecular Biology 108
- Statistics and Probability 84
- Pediatrics, Perinatology and Child Health 82
Countries citing papers authored by M. O. Karlsson
This map shows the geographic impact of M. O. Karlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. O. Karlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. O. Karlsson more than expected).
Fields of papers citing papers by M. O. Karlsson
This network shows the impact of papers produced by M. O. Karlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. O. Karlsson. The network helps show where M. O. Karlsson may publish in the future.
Co-authorship network of co-authors of M. O. Karlsson
This figure shows the co-authorship network connecting the top 25 collaborators of M. O. Karlsson. A scholar is included among the top collaborators of M. O. Karlsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. O. Karlsson. M. O. Karlsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 22 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 65 | |
| 8 | 64 | |
| 9 | 109 | |
| 10 | 23 | |
| 11 | 63 | |
| 12 | 39 | |
| 13 | Haematological toxicity following different dosing schedules of 5-fluorouracil and epirubicin in rats. | 7 |
| 14 | 124 | |
| 15 | 58 | |
| 16 | 14 | |
| 17 | Pharmacokinetics of disodium clodronate after daily intravenous infusions during five consecutive days. | 25 |
About M. O. Karlsson
M. O. Karlsson is a scholar working on Pharmacology, Statistics and Probability and Oncology, having authored 17 papers that have together received 623 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Statistical Methods in Clinical Trials (4 papers). The work is most often cited by research in Pharmacology (119 citations), Statistics and Probability (84 citations) and Oncology (272 citations). M. O. Karlsson has collaborated with scholars based in Sweden, Netherlands and United States. Frequent co-authors include E. Niclas Jonsson, Janet R. Wade, Curtis G. Wiltse, Marie Sandström, Agneta Freijs, Alex Sparreboom, Lena E. Friberg, Arne Melander, Anders Jönsson and Tony Rydberg. Their work appears in journals such as Journal of Clinical Oncology, Journal of Pharmacology and Experimental Therapeutics and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.